Licensing agreements

Entering into a franchise agreement can be a highly lucrative venture for both franchisors and franchisees. For the franchisor, it allows for expansion without requiring the same level of capital investment as direct company-owned locations. For the franchisee, it offers a chance to operate a business with an established brand, tested systems and, ideally, an […]

The transition towards a more sustainable energy future has placed a renewed focus on energy storage technologies. As renewable energy sources such as wind and solar become increasingly prominent, the need to store excess energy for later use becomes essential. At the heart of this transition is a growth in the development and deployment of

Patents play a crucial role in the pharmaceutical industry, granting companies exclusivity for a defined period and enabling them to recoup research and development investments. However, when these patents expire, the landscape undergoes a significant shift. The end of exclusivity brings competition, affects licensing agreements, and alters market dynamics. Understanding the ramifications of patent expirations

Telemedicine has witnessed an unprecedented boom in recent years, spurred by technological advancements and shifting healthcare dynamics. It enables medical practitioners to extend their services far beyond geographical restrictions, improving accessibility and patient outcomes. However, with this expansion comes the challenge of ensuring compliance with legal and regulatory frameworks. Licensing agreements play a critical role

Innovations in biotechnology have the potential to revolutionise healthcare, agriculture, and environmental sciences. However, bringing these innovations from the laboratory to the marketplace requires careful consideration of legal frameworks. Licensing agreements form a critical part of this process, ensuring that intellectual property (IP) rights are protected while enabling commercialisation. Drafting and negotiating a biotech licensing

Open source software (OSS) has transformed the technology industry by enabling collaboration, innovation, and cost-effective development. However, companies looking to build a business around such software face unique challenges when it comes to monetisation. The core issue is that open source licences grant users extensive freedoms, which can make traditional commercial models less effective. Thus,

As artificial intelligence continues to evolve, its impact on society grows more profound. From decision-making in financial institutions to generative models that create art, music, and written content, AI is no longer just a tool but a transformative force. This rapid expansion, however, also raises serious ethical and legal concerns. Who owns AI-generated content? How

The emergence of blockchain technology has revolutionised the way digital assets and intellectual property are managed, offering unprecedented levels of transparency, security, and efficiency. One of the most significant areas of impact is licensing, where blockchain is enabling new frameworks for rights management across industries such as media, software, and digital content. However, while blockchain’s

Artificial Intelligence (AI) and Machine Learning (ML) have rapidly transformed various industries, driving innovation in healthcare, finance, transportation, and beyond. These technologies have become indispensable tools for automating tasks, optimising processes, and enhancing decision-making. However, as AI and ML models become more advanced and widely deployed, legal challenges surrounding their licensing, ownership, and compliance have

Licensing agreements play a crucial role in the gaming industry, enabling developers to use intellectual property (IP), distribute content, and expand market reach. These contracts form the foundation of collaborations between game developers, publishers, IP owners, and distribution platforms. However, licensing agreements come with complex legal considerations that, if not carefully negotiated, can lead to